IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,526 | +10.6% | 210 | 0.0% | 0.00% | – |
| Q2 2023 | $8,616 | +14.8% | 210 | 0.0% | 0.00% | – |
| Q1 2023 | $7,505 | +150000.0% | 210 | +68.0% | 0.00% | – |
| Q4 2022 | $5 | -99.9% | 125 | 0.0% | 0.00% | – |
| Q3 2022 | $6,000 | -45.5% | 125 | -59.2% | 0.00% | – |
| Q2 2022 | $11,000 | -21.4% | 306 | -17.1% | 0.00% | – |
| Q1 2022 | $14,000 | -81.6% | 369 | -85.2% | 0.00% | -100.0% |
| Q4 2021 | $76,000 | +660.0% | 2,490 | +744.1% | 0.00% | – |
| Q3 2021 | $10,000 | -16.7% | 295 | 0.0% | 0.00% | – |
| Q2 2021 | $12,000 | -88.9% | 295 | -88.2% | 0.00% | -100.0% |
| Q1 2021 | $108,000 | – | 2,504 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |